Scientists found that low doses of an antibiotic can gently alter gut bacteria to boost production of compounds linked to longer life. In animal studies, this approach extended lifespan and improved metabolic health without harmful side effects.
The researchers showed that a low dose of the antibiotic cephaloridine prompts gut microbes to make more colanic acid, a bacterial compound already known to support longevity. Worms exposed to this treatment lived longer, and mice showed healthier metabolism, including improved cholesterol and insulin levels.
Crucially, cephaloridine stays in the gut and doesn’t enter the bloodstream, allowing it to influence bacteria without affecting the rest of the body. The findings suggest a new drug strategy: targeting gut microbes to produce health-promoting molecules, rather than acting directly on human cells.